NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required) | RFA CA 20 057

Opportunity Information: Apply for RFA CA 20 057

The NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required), identified as RFA-CA-20-057 under CFDA 93.398, is a National Institutes of Health grant program run through the National Cancer Institute that is built to move highly promising postdoctoral researchers into fully independent academic research careers as quickly and smoothly as possible. The central idea is to keep a strong pipeline of new, NCI-supported cancer investigators by backing people who are already well trained (holding a research doctorate and/or a clinical doctoral degree) and who are not expected to need a long additional stretch of mentored training beyond what they have already completed. In practical terms, the award is meant to help an outstanding postdoc convert momentum from their mentored fellowship period into a faculty-level, tenure-track (or equivalent) position with independent research support in hand, so they can establish a lab or independent program and compete effectively for future major grants.

The award mechanism is the NIH K99/R00 "Pathway to Independence" structure, which is specifically designed as a two-phase transition. The first phase (K99) supports the final portion of mentored postdoctoral training, positioning the candidate to complete key career development steps, strengthen their publication and preliminary data portfolio, and finish the mentored work needed to be competitive on the faculty job market. The second phase (R00) provides independent research support once the awardee secures an independent faculty appointment, allowing them to launch their own research direction and rapidly build an independent funding track record. This particular funding opportunity is the "Independent Clinical Trial Required" version, meaning the proposed work is expected to include an independent clinical trial component consistent with NIH definitions and requirements for clinical trials under this FOA.

From a scientific priority standpoint, the NCI explicitly encourages applications in data science and cancer control science, signaling strong interest in researchers who can advance cancer-related discovery and impact through areas like computational methods, informatics, modeling, statistics, machine learning, implementation research, population sciences, prevention, screening, survivorship, health services, and interventions that improve outcomes and equity. While those areas are highlighted, the broader purpose remains the development of a strong cohort of independent cancer researchers, so projects aligned with NCI mission areas are generally within scope as long as they match the FOA's clinical trial expectation.

Eligibility in the source information emphasizes broad institutional participation across the U.S. research ecosystem. Eligible applicant organizations include many types of domestic entities such as public and state-controlled institutions of higher education, private institutions of higher education, state and local governments (including counties, cities, townships, and special districts), independent school districts, federally recognized Native American tribal governments, tribal organizations (including those other than federally recognized tribal governments), public housing authorities/Indian housing authorities, nonprofits with or without 501(c)(3) status (other than institutions of higher education), for-profit organizations other than small businesses, and small businesses. The opportunity also highlights interest in participation from institutions and organizations that often serve underrepresented communities or specific regions, including Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving institutions, historically Black colleges and universities, tribally controlled colleges and universities, faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.

At the same time, the FOA draws clear boundaries around non-U.S. involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as applicant organizations, and non-domestic components of U.S. organizations are not eligible. However, foreign components are permitted when they meet NIH Grants Policy Statement definitions and are appropriately justified, which typically means that while the grant must be held and administered by an eligible U.S.-based organization, certain discrete project elements may occur abroad if they are necessary and well supported.

Administrative details in the provided record include that the opportunity is categorized as a discretionary grant within education and health activity areas, was created on 2020-10-28, and listed an original closing date of 2021-02-26. The award ceiling and expected number of awards are not specified in the provided source fields. Overall, the program is best understood as a career acceleration mechanism: it targets exceptional postdoctoral researchers who are ready for independence, provides structured support through the transition, and aims to help them secure faculty roles and quickly establish competitive, independent cancer research programs, with particular encouragement for candidates working in data science and cancer control science and with clinical trial requirements built into the expected research plan.

• The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.398.
• This funding opportunity was created on 2020-10-28.
• Applicants must submit their applications by 2021-02-26. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA CA 20 057

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: